What’s next in Indonesia’s healthcare landscape: Digital transformation, preventive care, and early detection
The Indonesian healthcare landscape has improved significantly in the past decade. It has strengthened access to funding through the successful rollout of the BPJS Kesehatan, or universal healthcare, and the successful reforms implemented through the Omnibus Law that we will see in the coming years.
Mesh Bio: The role of deep tech in modern healthcare
What if we can prevent catastrophic diseases such as diabetes, kidney failure, and stroke with deep tech? The word deep tech might still be unfamiliar to people’s ears as it first emerged in 2014.
East Ventures and NalaGenetics’ commitment to supporting genomic sample analysis at the Biomedical and Genome Science Initiative (BGSi)
East Ventures, a pioneering and leading venture capital (VC) firm in Indonesia and Southeast Asia, has signed a Memorandum of Understanding (MoU) with NalaGenetics, a biotechnology company focused on personalized medicine, diet, and screening. This partnership is aimed to support genomic sample analysis in Indonesia's Biomedical and Genome Science Initiative (BGSi). The ceremonial signing of this MoU took place at the East Ventures booth during the Tech in Asia Conference 2023 and was attended by Budi Gunadi Sadikin, Minister of Health of the Republic of Indonesia.
East Ventures announced its first Healthcare fund of US$30 million
East Ventures, a pioneering and leading venture capital firm in Indonesia and Southeast Asia, today announced the firm’s first healthcare-focused fund with the amount of US$30 million, which is dedicated to supporting innovative healthcare solutions in Indonesia.
Aevice Health secures investment from East Ventures to bring next-generation remote respiratory platform to Southeast Asia
Aevice Health, a leading provider of remote respiratory monitoring solutions for the healthcare continuum based in Singapore, today announced that it has raised undisclosed funding from East Ventures, a pioneering and leading sector-agnostic venture capital firm focusing on Southeast Asia.
Genetic testing: Leading the way in preventive care for Southeast Asia
In a region plagued by diseases such as heart disease, stroke, cancer, diabetes and neonatal deaths, NalaGenetics is taking a stand. As a prominent provider of genetic testing solutions, this pioneering company is on a mission to combat these ailments and improve patient outcomes in Southeast Asia.
Biotechnology and the future of healthcare in Indonesia
Indonesia generates millions of tonnes of waste daily, making it one of the largest waste-producing countries globally. The country also has the highest municipal waste in Southeast Asia, creating a pressing problem that affects public health, the environment, and the economy. But amidst this crisis lies an opportunity. Entrepreneurs and innovators can create sustainable solutions that can transform waste management practices in Indonesia.
AMILI, a precision gut microbiome firm, raises new funding led by East Ventures
AMILI, Southeast Asia’s first and only precision gut microbiome company, today announced that it has secured new funding from East Ventures, a pioneering sector-agnostic venture capital firm that has supported over 300 tech companies across Southeast Asia. This fund strengthens AMILI’s balance sheet, following the company’s series A funding in June 2022.